The purpose of the present study was to investigate the relationship of expression of hypoxia inducible factor ( HIF ) -1 - modifying enzymes prolyl hydroxylase ( PHD ) 1 , PHD2 and PHD3 to response of tumours and survival in breast cancer patients enrolled in a phase II trial of neoadjuvant anthracycline and tamoxifen therapy .
